{"authors": [["Oztan", "Ozge", "O", "Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States. Electronic address: ooztan@stanford.edu."], ["Jackson", "Lisa P", "LP", "Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States."], ["Libove", "Robin A", "RA", "Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States."], ["Sumiyoshi", "Raena D", "RD", "Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States."], ["Phillips", "Jennifer M", "JM", "Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States."], ["Garner", "Joseph P", "JP", "Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States; Department of Comparative Medicine, Stanford University, Stanford, CA 94305, United States."], ["Hardan", "Antonio Y", "AY", "Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States."], ["Parker", "Karen J", "KJ", "Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States."]], "doi": "10.1016/j.psyneuen.2017.12.022", "date": "2018-01-16_23:18:49", "journal": ["Psychoneuroendocrinology", "Psychoneuroendocrinology"], "year": null, "title": "Biomarker discovery for disease status and symptom severity in children with autism.", "id": "29309996", "text": ["autism", "spectrum", "disorder", "asd", "characterized", "social", "impairments", "repetitive", "behaviors", "affects", "1", "68", "us", "children", "despite", "asd", "societal", "impact", "disease", "mechanisms", "remain", "poorly", "understood", "recent", "preclinical", "asd", "biomarker", "discovery", "research", "implicated", "neuropeptides", "oxytocin", "oxt", "arginine", "vasopressin", "avp", "receptors", "oxtr", "avpr1a", "animal", "models", "efforts", "translate", "findings", "individuals", "asd", "typically", "involved", "evaluating", "single", "neuropeptide", "measures", "biomarkers", "asd", "behavioral", "functioning", "given", "asd", "heterogeneous", "disorder", "unidimensional", "asd", "biomarker", "studies", "challenging", "reproduce", "employed", "multidimensional", "neuropeptide", "biomarker", "analysis", "powerfully", "interrogate", "disease", "status", "symptom", "severity", "well", "characterized", "child", "cohort", "comprised", "asd", "patients", "neurotypical", "controls", "neuropeptide", "measures", "considered", "whole", "correctly", "predicted", "disease", "status", "57", "68", "84", "participants", "analysis", "revealed", "composite", "measure", "oxtr", "avpr1a", "gene", "expression", "key", "driver", "group", "classification", "children", "asd", "lower", "neuropeptide", "receptor", "mrna", "levels", "compared", "controls", "lower", "neuropeptide", "receptor", "mrna", "levels", "also", "predicted", "greater", "symptom", "severity", "core", "asd", "features", "social", "impairments", "stereotyped", "behaviors", "unrelated", "intellectual", "impairment", "associated", "feature", "asd", "findings", "research", "highlight", "value", "assessing", "multiple", "related", "biological", "measures", "relative", "contributions", "study", "suggest", "low", "blood", "neuropeptide", "receptor", "availability", "may", "promising", "biomarker", "disease", "presence", "symptom", "severity", "asd"]}